Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 16, 2026 954.90M
November 13, 2026 967.94M
November 12, 2026 1.004B
November 11, 2026 1.027B
November 10, 2026 1.025B
November 09, 2026 1.056B
November 06, 2026 1.043B
November 05, 2026 964.68M
November 04, 2026 1.053B
November 03, 2026 964.68M
November 02, 2026 935.35M
October 30, 2026 977.72M
October 29, 2026 1.007B
October 28, 2026 1.010B
October 27, 2026 1.017B
October 26, 2026 938.61M
October 23, 2026 922.32M
October 22, 2026 936.98M
October 21, 2026 974.46M
October 20, 2026 971.20M
October 19, 2026 915.80M
October 16, 2026 811.51M
October 15, 2026 847.36M
October 14, 2026 775.67M
October 13, 2026 798.48M
Date Value
October 12, 2026 980.97M
October 09, 2026 1.095B
October 08, 2026 1.075B
October 07, 2026 1.075B
October 06, 2026 1.062B
October 05, 2026 1.095B
October 02, 2026 1.141B
October 01, 2026 1.177B
September 30, 2026 1.219B
September 29, 2026 1.225B
September 28, 2026 1.225B
September 25, 2026 1.121B
September 24, 2026 1.160B
September 23, 2026 1.199B
September 22, 2026 1.280B
September 21, 2026 1.241B
September 18, 2026 1.234B
September 17, 2026 1.280B
September 16, 2026 1.251B
September 15, 2026 1.248B
September 14, 2026 1.231B
September 11, 2026 1.234B
September 10, 2026 1.280B
September 09, 2026 1.339B
September 08, 2026 1.384B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Imunon, Inc. 6.587M
Altimmune, Inc. 74.58M
Agenus, Inc. 468.04M
Amgen, Inc. 290.89B
Anika Therapeutics, Inc. 154.24M

Enterprise Value Related Metrics